Save Natural Pain Treatment!

The Drug Enforcement Agency (DEA) is moving against cannabidiol (CBD), a supplement used to control pain and inflammation. The circumstances are extremely suspicious.

Late last year, the DEA published a final rule that classifies marijuana and hemp extracts, including CBD, as Schedule 1 controlled substances—a category that includes heroin, LSD, mescaline, and MDMA. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana—only the non-psychoactive painkilling chemicals.

This is not a merely irrational move by the DEA—it’s a deeply suspicious one. The US government holds a patent on CBD that covers the use of CBD to protect the brain from degeneration and the treatment of diseases like Alzheimer’s and Parkinson’s.

Sound familiar? The US Food and Drug Administration (FDA) has been obsessed with natural remedies that can treat Alzheimer’s. So far, the agency has attacked supplements such as picamilon, vinpocetine, and pyridoxamine, essentially clearing the field for expensive Big Pharma-owned Alzheimer’s drugs that they know don’t work. The government seems to be employing the same playbook against CBD.

Send a message to the DEA, with a copy to Congress, telling them to reverse this flawed decision.

Recipients

Your Senators
Your Representative
Drug Enforcement Agency

Contact

*Required fields

* Title:

* First Name:

* Last Name:

* Your Email:

* Address 1:

Address 2:

* City:

* State / Province:

* ZIP / Postal Code:

Country:

* Phone Number:

Yes, I would like to receive periodic updates and communications from Alliance for Natural Health USA.

Remember me. What's this?

Message

Please maintain access to CBD

Dear [Decision Maker],

* Personalize your message

The DEA published a final rule that classifies marijuana and hemp extracts, including CBD, as Schedule 1 controlled substances. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana--only the non-psychoactive painkilling chemicals.

There are thousands of published scientific studies on CBD and its beneficial health effects on pain, inflammation, seizures, rheumatoid arthritis, and other inflammatory conditions. CBD is available as a dietary supplement.

This is not a merely irrational move by the DEA--it's a deeply suspicious one. The US government holds a patent on CBD that covers the use of CBD to protect the brain from degeneration and the treatment of diseases like Alzheimer's and Parkinson's.

So, on one hand, the government is saying there is "no accepted medical use" for CBD by classifying it as a Schedule 1 drug, which would normally remove CBD from the market as a supplement. On the other hand, the Department of Health and Human Services (HHS) has a patent that says there are important medical uses for it!

Please reverse the decision to categorize CBS as a Schedule 1 substance. I'm sending a copy of this message to me representatives so Congress learns of this dubious move.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]